Oura Launches IPO Roadshow with $2.2 Billion Target
Oura, a wearable health technology company known for its smart ring that tracks sleep, activity, and heart metrics, has launched its initial public offering (IPO) targeting up to $2.2 billion from the sale of 50 million shares priced between $40 and $44 each. The IPO is set to list on Nasdaq under the ticker symbol 'OURA,' with trading expected to begin next week. Of the total shares, Oura will offer 13.5 million while existing stockholders sell the remaining 36.5 million. Underwriters also have an option to purchase up to 7.5 million additional shares within 30 days. The offering values the company at a fully diluted valuation of $15.62 billion, with major investors like Eli Lilly and Dragoneer signaling interest in purchasing significant portions of the IPO. The roadshow comes amid cautious market conditions due to AI sector volatility, rising bond yields, and uncertainty around Fed rate decisions.
